Cargando…
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
The omega-3 fatty acid eicosapentaenoic acid (EPA) has multiple actions potentially conferring cardiovascular benefit, including lowering serum triglyceride (TG) and non-high-density lipoprotein cholesterol (non-HDL-C) levels and potentially reducing key steps in atherogenesis. Dietary supplements a...
Autores principales: | Brinton, Eliot A., Mason, R. Preston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870/ https://www.ncbi.nlm.nih.gov/pubmed/28137294 http://dx.doi.org/10.1186/s12944-017-0415-8 |
Ejemplares similares
-
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
por: Mason, R. Preston, et al.
Publicado: (2020) -
Chronic Psychological Stress Was Not Ameliorated by Omega-3 Eicosapentaenoic Acid (EPA)
por: Bradbury, Joanne, et al.
Publicado: (2017) -
The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
por: Reiner, Martin F., et al.
Publicado: (2021) -
Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids
por: Khan, Safi U., et al.
Publicado: (2021) -
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function
por: Ochi, Eisuke, et al.
Publicado: (2018)